Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 2 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 26Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Prostatic Neoplasms 8Multiple Myeloma 8Lung Neoplasms 7Melanoma 5Leukemia, Myeloid, Acute 5Neoplasm Metastasis 4Glioma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Tuberous Sclerosis 3Stomach Neoplasms 3Sarcoma 3Papillomavirus Infections 3Leiomyoma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Renal Cell 3Venous Thromboembolism 2Rectal Neoplasms 2Polycythemia Vera 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Obesity 2Neoplasms by Site 2Myasthenia Gravis 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Pain × 90 days × Clear all
NCT00771199 2026-06-04

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Janssen-Cilag Ltd.

Phase 4 Completed
14 enrolled

Cancer Pain, Neoplasms, Pain

NCT05088876 2026-04-13

ParOP

Insel Gruppe AG, University Hospital Bern

Phase 4 Terminated
7 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡